Patents by Inventor David Charles Baulcombe

David Charles Baulcombe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140331361
    Abstract: Compositions and methods are disclosed for effecting gene silencing (e.g., post transcriptional gene silencing) in an organism by targeting 15-20 nucleotides of mRNA.
    Type: Application
    Filed: July 15, 2014
    Publication date: November 6, 2014
    Inventors: David Charles BAULCOMBE, Andrew John HAMILTON
  • Patent number: 8871997
    Abstract: Disclosed are a variety of methods for achieving enhanced expression from a target nucleotide sequence in a plant e.g. comprising the step of transiently introducing into a tissue of a plant (e.g. a leaf) a first nucleic acid comprising the target nucleotide sequence and a second nucleic acid encoding a Post Transcriptional Gene Silencing (PTGS) suppressor protein (preferably of viral or plant origin), wherein the first and second nucleic acids are comprised within a single binary vector, construct, or the first and second nucleic acid sequences are comprised within a first binary vector and a second binary vector construct respectively. The plant tissue may then be harvested for the protein. Such methods can give much higher levels of gene expression than are obtainable using stable transgenes, or certain replicating vectors.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: October 28, 2014
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Olivier Voinnet, Andrew John Hamilton
  • Patent number: 8779236
    Abstract: Methods are disclosed for screening for the occurrence of gene silencing (e.g., post transcriptional gene silencing) in an organism. Also provided are methods for isolating silencing agents so identified.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: July 15, 2014
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 8759102
    Abstract: Cells that have been exogenously supplied with short RNA molecules to effect posttranscriptional gene silencing are described.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: June 24, 2014
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 8349607
    Abstract: Methods are disclosed for screening for the occurrence of gene silencing (e.g., post transcriptional gene silencing) in an organism. Also provided are methods for isolating silencing agents so identified.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: January 8, 2013
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 8299235
    Abstract: The invention is directed to compositions for gene silencing by providing short RNA molecules to cells.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: October 30, 2012
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 8263569
    Abstract: Methods are disclosed for gene silencing (e.g. post transcriptional gene silencing) in an organism using small RNA molecules.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: September 11, 2012
    Assignee: Plant Biosciences Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 8258285
    Abstract: The invention relates to short RNA molecules of about 25 nucleotides in length, which comprise antisense RNA complementary to a targeted mRNA and corresponding sense RNA molecules. These short RNA molecules are effective in post-transcriptional gene silencing (PTGS).
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: September 4, 2012
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 8097710
    Abstract: A method to silence a gene in cells by post-transcriptional gene silencing is described which method employs short RNA molecules (SRMs). SRMs are short sense RNA molecules (SSRMs) and short antisense RNA molecules (SARMs) which SARMs are complementary to a region of a target RNA transcribed from a gene to be silenced and said SSRMs correspond to the sequence of the target RNA.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: January 17, 2012
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Patent number: 7704688
    Abstract: Methods are disclosed for screening of the occurrence of gene silencing (e.g. post transcriptional gene silencing) in an organism. Also provided are methods for isolating silencing agents so identified.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: April 27, 2010
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Publication number: 20090286254
    Abstract: Methods are disclosed for screening for the occurrence of gene silencing (e.g., post transcriptional gene silencing) in an organism. Also provided are methods for isolating silencing agents so identified.
    Type: Application
    Filed: July 23, 2009
    Publication date: November 19, 2009
    Inventors: David Charles BAULCOMBE, Andrew John HAMILTON
  • Publication number: 20090288182
    Abstract: Methods are disclosed for screening for the occurrence of gene silencing (e.g., post transcriptional gene silencing) in an organism. Also provided are methods for isolating silencing agents so identified.
    Type: Application
    Filed: July 23, 2009
    Publication date: November 19, 2009
    Inventors: David Charles BAULCOMBE, Andrew John HAMILTON
  • Publication number: 20080312176
    Abstract: Methods are disclosed for gene silencing (e.g. post transcriptional gene silencing) in an organism using small RNA molecules.
    Type: Application
    Filed: May 30, 2008
    Publication date: December 18, 2008
    Inventors: David Charles BAULCOMBE, Andrew John Hamilton
  • Patent number: 7217854
    Abstract: Disclosed are a variety of methods for achieving enhanced expression from a target nucleotide sequence in a plant e.g. comprising the step of transiently introducing into a tissue of a plant (e.g. a leaf) a first nucleic acid comprising the target nucleotide sequence and a second nucleic acid encoding a Post Transcriptional Gene Silencing (PTGS) suppressor protein (preferably of viral or plant origin), wherein the first and second nucleic acids are comprised within a single binary vector construct, or the first and second nucleic acid sequences are comprised within a first binary vector and a second binary vector construct respectively. The plant tissue may then be harvested for the protein. Such methods can give much higher levels of gene expression than are obtainable using stable transgenes, or certain replicating vectors.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: May 15, 2007
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Olivier Voinnet, Andrew John Hamilton
  • Patent number: 6753139
    Abstract: Methods are disclosed for screening for the occurrence of gene silencing (e.g., post transcriptional gene silencing) in an organism. Also provided are methods for isolating silencing agents so identified.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: June 22, 2004
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Andrew John Hamilton
  • Publication number: 20040078844
    Abstract: Provided are insolated DNA vectors which may be based on Agrobacterium binary vectors and which comprise: (a) a transfer nucleotide sequence comprising (i) a plant active promoter, operably linked to (ii) a recombinant tobacco rattle virus (TRV) nucleic acid which may corresponds to all or part of TRV RNA 1 and which includes: a sequence encoding a TRV trans acting factor, and cis acting elements, which confer on the TRV nucleic acid transcript the ability to replicate in the cytoplasm of a plant cell; and a heterologous nucleotide sequence which is foreign to said virus (which may be a cloning site, or a targeting sequence which is capable of down-regulating expression of a target gene); (b) border sequences which permit the transfer of the transfer nucleotide sequence into a plant cell genome. Preferred vectors include pBTA&Dgr;AMP&Dgr;16K (SEQ ID NO: 3) or pBTA&Dgr;MP (SEQ ID NO: 2). Also provided are related materials and methods of use of such vectors e.g.
    Type: Application
    Filed: September 30, 2003
    Publication date: April 22, 2004
    Inventors: David Charles Baulcombe, Ana Monserrat Martin-Hernandez
  • Publication number: 20030229920
    Abstract: Disclosed are methods for silencing a target nucleotide sequence (preferably representing one or more endogenous genes, preferably in a systemic fashion) which is present in a first part of the plant, which method comprises transiently introducing into the cytoplasm of a cell in a second part of the plant, which cell comprises a nucleic acid encoding the target sequence and which is remote from said first part of the plant, a nucleic acid construct.
    Type: Application
    Filed: March 5, 2003
    Publication date: December 11, 2003
    Inventors: David Charles Baulcombe, Olivier Voinnet, Carsten Werner Lederer
  • Patent number: 6635805
    Abstract: The invention presents DNA constructs comprising a promoter operably linked to DNA which can be transcribed in a plant cell to an RNA transcript, wherein the RNA transcript comprises plant virus sequence from an RNA virus which confers on the RNA transcript the ability to replicate in the cytoplasm of the plant cell, wherein the transcript lacks all or part of the viral genome not required for replication in the cytoplasm, and further comprises at least one targeting sequence which is foreign to the plant virus sequence and causes post-transcriptional gene silencing of one or more target genes. The invention also presents methods to use the DNA construct to cause post-transcriptional gene silencing of a target gene in a plant.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: October 21, 2003
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Susan Mary Angell
  • Patent number: 6531647
    Abstract: Disclosed are methods for silencing a target nucleotide sequence (preferably representing one or more endogenous genes, preferably in a systemic fashion) which is present in a first part of the plant, which method comprises transiently introducing into the cytoplasm of a cell in a second part of the plant, which cell comprises a nucleic acid encoding the target sequence and which is remote from said first part of the plant, a nucleic acid construct.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: March 11, 2003
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Olivier Voinnet, Carsten Werner Lederer
  • Patent number: 6369296
    Abstract: Disclosed are nucleic acid vectors which comprise: (a) a transfer nucleotide sequence comprising (i) a plant active promoter, operably linked to (ii) a recombinant tobacco rattle virus (TRV) cDNA (preferably derived from TRV RNA2) which includes at least cis acting elements permitting replication of the cDNA; a subgenomic promoter operably linked to a sequence encoding a TRV coat protein; and a heterologous nucleotide sequence which is foreign to the virus;(b) border sequences which permit the transfer of the transfer nucleotide sequence into a plant genome. Such vectors may be used as expression vectors or for achieving viral induced gene silencing (VIGS) of a target gene, wherein the heterologous nucleotide sequence is a targeting sequence which corresponding to that gene. Example vectors include pTV00 and vectors which are derived from PTV00 and have the characteristics thereof. Also disclosed are associated processes, methods, viruses or viral particle, kits, host cells and plant tissues.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: April 9, 2002
    Assignee: Plant Bioscience Limited
    Inventors: Frank Giles Ratcliff, Ana Montserrat Martin-Hernandez, David Charles Baulcombe